Resolvin inflammation with pain

Expert Opinion on Investigational Drugs

Volumn 19, Issue 11, 2010, Pages 1461-1464

  Doggrell, Sheila A ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

animal models; inflammation; pain; resolvins; RvD1; RvE1

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; DOCOSAHEXAENOIC ACID; GABAPENTIN; HARKOSERIDE; MORPHINE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PREGABALIN; RESOLVIN; RESOLVIN D1; RESOLVIN E1; RESOLVIN E2; RESOLVIN F1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ASTHMA; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; EDEMA; HYPERALGESIA; INFLAMMATION; NEUROPATHIC PAIN; NONHUMAN; PAIN; POSTOPERATIVE PAIN; REPERFUSION INJURY; SHORT SURVEY;

EID: 77958464789     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.2010.527946     Document Type: Short Survey

References (16)

1. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fist: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010;68:280-9
2. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzionne trial. Lancet 1999;354:447-55
3. Serhan CN, Clish CB, Brannon J, et al. Novel functional sets of lipid-derived mediators with anti-inflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000;192:1197-204
4. Xu ZZ, Zhang L, Liu T, et al. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Medicine 2010;16:592-7
5. Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 2008;153:S200-15
6. Hong S, Gronert K, Devehand PR, et al. Novel docosatrienes and 17S-resolvings, generated from docosahexaenoic acid in murine brain, human blood and glial cells. J Biol Chem 2003;278:14677-87
7. Krishnamoorthy S, Recchiutiu A, Chiang N, et al. Resolvin D1 binds human phagocytes with evidence of proresolving receptors. Proc Natl Acad Sci USA 2010;107:1660-5
8. Aoki H, Hisada T, Ishizuka T, et al. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Comm 2008;367:509-15
9. Keyes KT, Ye Y, Lin Y, et al. Resolvin E1 protects the heart against reperfusion injury. Am J Physiol Heart Circ Physiol 2010;299:H153-64
10. Marcheselli VL, Hong S, Lukiw WJ, et al. Novel docasanoids inhibit brain-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003;278:43807-17
11. Sun YP, Oh SF, Uddin J, et al. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 2007;282:9323-34
12. Duffield JS, Hong S, Vaidya VS, et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 2006;177:5902-11
13. Sommer C, Birklein F. Fighting offpain with resolvins. Nat Medicine 2010;16:518-20
14. Beyreuther BK, Geis C, Stohr T, Somner C. Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Neuropharmacology 2007;52:1312-17
15. Ziegler D, Hidvegi T, Gurieva I, et al. Efficacy and safety of lacosamide in painful diabetic neuropathy. Diabetes Care 2010;33:839-41
16. Tesfaye S. Advances in the management of diabetic peripheral neuropathy. Curr Opin Support Palliat Care 2009;33:136-43